ChristopherCarrollSmith

Usually gold and the dollar move opposite directions, but both XAUUSD and DXY are up since late June. The dollar index is holding above its upward trend line and poised to possibly bounce higher in the coming week. Meanwhile, gold is in overbought territory on the RSI and making bearish...

Ameritrade (like the financial sector as a whole) is way down, primarily due to the Fed's July interest rate cut. In my opinion, this has been a big overreaction. Ameritrade posted an earnings beat and upward guidance revision just before the Fed announcement, but the rate cut eclipsed Ameritrade's good news. Ameritrade has significant support levels around 43...

Donald Trump's announcement of new tariffs and the Fed's signal that we will only get one rate cut this year have sent indices tumbling. Rising from the chaos are small cap stocks. The last few days, EWSC rose against the S&P and got a big surge in volume relative to the volume in the large cap space. A volume surge like this in small caps often signals the...

SOXL attempted a breakout above its channel and above April's highs, but got rejected and dropped back down to support at the 50-hour moving average. Here it's showing renewed strength, with volume turning green and candlesticks looking bullish. I think it will make another run at 202, this time pushing through to previous highs around 208. SOXL has strong...

It's been a banner quarter for large-cap pharmaceutical companies. We've had earnings beats and guidance upgrades from GlaxoSmithKline, Biogen, Bristol-Myers Squibb, Merck, Celgene, and Procter & Gamble. More earnings beats may be coming, with Amgen reporting today after market and Amarin tomorrow. In my opinion, the whole sector is set to surge, and the leveraged...

Hillenbrand has an 8.1/10 Equity Summary Score from Thompson Reuters StarMine with earnings coming up Wednesday. Hillenbrand has beaten analyst estimates 7 out of the last 8 quarters. The company's recent share price weakness makes it a good candidate for a pop in the event of an earnings beat. Hillenbrand may also have an additional positive catalyst coming....

Amgen is attempting a breakout above its one-month downward trend line this morning. I will wait to enter until I see a change in volume. Currently there's bearish divergence on the volume profile, which suggests that this may correct downward before confirming the breakout. Amgen reports earnings tomorrow, and has a positive earnings surprise prediction from...

The printing business isn't exactly a booming industry, and ARC Document Solutions has fallen nearly 50% since its 2018 peak, and even more than that since 2017. However, ARC is a surprisingly strong company in this space. For the full year 2018, it increased its revenue, sales, earnings, and cash flow over its 2017 numbers. The company's full year guidance for...

The semiconductor has been hot lately, with recent earnings beats from MU, INTC, TSM, and TXN. These companies' performance implies that demand in this sector has recovered faster than analysts expected. That bodes well for Qualcomm, which posts earnings results Wednesday. The Zacks Earnings Surprise Prediction is 0%. However, QCOM has a long history of beating...

Exelixis broke above a downward sloping trend line and also pushed above its 20-hour EMA. It's also above the Hull Moving Average and has uptrending RSI and MACD with plenty of room to run before it gets overbought. This is a lovely trend line break with a likely run to at least 21 before next downward oscillation. Exelixis reports earnings on July 31, with an 8%...

Deere has surged upward through both recent highs and the top of its ascending wedge today. I don't love entering when it's so overbought and we're still 4 days away from the corner of the wedge, so I will hope for an oscillation downward. (But oh, the FOMO! Maybe I'll enter if we hold above the wedge and also close a bar above the Hull Moving Average.)

Private prisons aren't sexy, and CoreCivic has been collapsing due to negative publicity around its management of detention centers for migrant children on behalf of the US government. This, however, presents an opportunity for the contrarian investor. Despite an analyst downgrade a couple days ago from Fitch, CoreCivic has been seeing an acceleration of bullish...

Revolve just broke upward through its downward trend line ahead of earnings. I hesitate to buy this breakout because it happened so suddenly, and big green candles like that have a tendency to reverse themselves. However, I will buy if it pulls back.

Wow. I noticed this bullish trend line breakout first thing this morning and picked up a few shares, and it already hit my first target. Hopefully it will pull back a little from here and offer a buying opportunity to those who want it. It should stretch up to at least the next trend line in the next week or so.

UnitedHealth is making a bullish trend line breakout in the first hour of trading. After blowout earnings and a guidance revision, UNH is a great value at this price. I intend to hold this for a while.

Ahead of earnings, SFIX got an upgrade from the analytics firm Stifel, which cited SFIX's history of strong earnings and its attractive valuation. That appears to have driven a breakout above the stock's downward trend line today. Trend line breaks are usually bullish, and can lead to big gains like the PG&E trend line break I identified the other day. Others are...

Biogen has formed an ascending triangle. With strong earnings and a guidance upgrade, the catalysts favor upward breakout. However, certain aspects of Biogen's business are struggling and face increasing competition, so the stock could also fall. I will play oscillations within the triangle by buying and selling crossovers of the green line, with stop losses in...

Investors seem to expect strong a strong earnings result from ULH tomorrow, given the big pop above its pennant today. I'm not going to buy it, however. This breakout comes a little too early in the pennant pattern for my comfort. Also, the big run up ahead of earnings may be setting this stock up for disappointment.